Prevention of diabetic nephropathy in rats through enhanced renal antioxidative capacity by inhibition of the proteasome

Life Sciences

Volumn 88, Issue 11-12, 2011, Pages 512-520

  Luo, Zhi Feng ^a   Qi, Wei ^a   Feng, Bing ^a   Mu, Jiao ^a   Zeng, Wei ^a   Guo, Yan Hong ^a   Pang, Qi ^a   Ye, Zi Lin ^a   Liu, Li ^a   Yuan, Fa Huan ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Antioxidant; Diabetic nephropathy; Oxidative stress; Proteasome inhibition

Indexed keywords

3 NITROTYROSINE; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CATALASE; COPPER ZINC SUPEROXIDE DISMUTASE; DNA 26S; GLUTATHIONE PEROXIDASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; PROTEASOME; PROTEIN P47; TRANSCRIPTION FACTOR NRF2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DRUG INDUCED DISEASE; ENZYME ACTIVITY; ENZYME INHIBITION; KIDNEY; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; RAT; URINARY EXCRETION;

ANIMALS; ANTIOXIDANTS; BLOTTING, WESTERN; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENZYME-LINKED IMMUNOSORBENT ASSAY; KIDNEY; LEUPEPTINS; MALE; OXIDATIVE STRESS; PROTEASE INHIBITORS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEINURIA; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

RATTUS;

EID: 79952455513     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2010.12.023     Document Type: Article

References (49)

1. H. Aebi Catalase in vitro Meth Enzymol 105 1984 121 126
2. N. Aksoy, H. Vural, T. Sabuncu, and S. Aksoy Effects of melatonin on oxidative-antioxidative status of tissues in streptozotocin-induced diabetic rats Cell Biochem Funct 21 2003 121 125 (Pubitemid 36597178)
3. S. Bieler, S. Meiners, V. Stangl, T. Pohl, and K. Stangl Comprehensive proteomic and transcriptomic analysis reveals early induction of a protective anti-oxidative stress response by low-dose proteasome inhibition Proteomics 12 2009 3257 3267
4. A.R. Chade, J. Herrmann, X. Zhu, J.D. Krier, A. Lerman, and L.O. Lerman Effects of proteasome inhibition on the kidney in experimental hypercholesterolemia J Am Soc Nephrol 16 2005 1005 1012 (Pubitemid 41710311)
5. B. Chen, Y. Ma, R. Meng, Z. Xiong, C. Zhang, and G. Chen MG132, a proteasome inhibitor, attenuates pressure-overload-induced cardiac hypertrophy in rats by modulation of mitogen-activated protein kinase signals Acta Biochim Biophys Sin Shanghai 42 2010 253 258
6. H. Dreger, K. Westphal, A. Weller, G. Baumann, V. Stangl, and S. Meiners Nrf2-dependent upregulation of antioxidative enzymes: a novel pathway for proteasome inhibitor-mediated cardioprotection Cardiovasc Res 83 2009 354 361
7. H. Dreger, K. Westphal, N. Wilck, G. Baumann, V. Stangl, and K. Stangl Protection of vascular cells from oxidative stress by proteasome inhibition depends on Nrf2 Cardiovasc Res 85 2010 395 403
8. D. Dutaud, L. Aubry, L. Henry, D. Levieux, K.B. Hendil, and L. Kuehn Development and evaluation of a sandwich ELISA for quantification of the 20S proteasome in human plasma J Immunol Meth 260 2002 183 193 (Pubitemid 34132884)
9. H. Farhangkhoee, Z.A. Khan, S. Mukherjee, M. Cukiernik, Y.P. Barbin, and M. Karmazyn Heme oxygenase in diabetes-induced oxidative stress in the heart J Mol Celluar Cardiol 35 2003 1439 1448 (Pubitemid 37491187)
10. L. Farout, J. Mary, J. Vinh, L.I. Szweda, and B. Friguet Inactivation of the proteasome by 4-hydroxy-2-nonenal is site specific and dependent on 20S proteasome subtypes Arch Biochem Biophys 453 2006 135 142
11. B. Feng, Y. Zhang, J. Mu, Z. Ye, W. Zeng, and W. Qi Preventive effect of a proteasome inhibitor on the formation of accelerated atherosclerosis in rabbits with uremia J Cardiovasc Pharmacol 55 2010 129 138
12. R. Fernandes, J. Ramalho, and P. Pereira Oxidative stress upregulates ubiquitin proteasome pathway in retinal endothelial cells Mol Vis 12 2006 1526 1535 (Pubitemid 46029773)
13. X. Gao, H. Zhang, A.M. Schmidt, and C. Zhang AGE/RAGE produces endothelial dysfunction in coronary arterioles in type 2 diabetic mice Am J Physiol Heart Circ Physiol 295 2008 H491 H498
14. K.H. Jeong, T.W. Lee, C.G. Ihm, S.H. Lee, J.Y. Moon, and S.J. Lim Effects of sildenafil on oxidative and inflammatory injuries of the kidney in streptozotocin-induced diabetic rats Am J Nephrol 29 2009 274 282
15. P. Kakkar, B. Das, and P.N. Viswanathan A modified spectrophotometric assay of superoxide dismutase Indian J Biochem Biophys 21 1984 130 132 (Pubitemid 15207169)
16. S. Kalayarasan, P.N. Prabhu, N. Sriram, R. Manikandan, M. Arumugam, and G. Sudhandiran Diallyl sulfide enhances antioxidants and inhibits inflammation through the activation of Nrf2 against gentamicin-induced nephrotoxicity in Wistar rats Eur J Pharmacol 606 2009 162 171
17. Y.S. Kanwar, J. Wada, L. Sun, P. Xie, E.I. Wallner, and S. Chen Diabetic nephropathy: mechanisms of renal disease progression Exp Biol Med 233 2008 4 11
18. Y.J. Kim, Y.A. Kim, and T. Yokozawa Attenuation of oxidative stress and inflammation by gravinol in high glucose-exposed renal tubular epithelial cells Toxicology 270 2010 106 111
19. G.J. Ko, Y.S. Kang, S.Y. Han, M.H. Lee, H.K. Song, and K.H. Han Pioglitazone attenuates diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats Nephrol Dial Transplant 23 2008 2750 2760
20. S. Kotamraju, S. Matalon, T. Matsunaga, T. Shang, J.M. Hickman-Davis, and B. Kalyanaraman Upregulation of immunoproteasomes by nitric oxide: potential antioxidative mechanism in endothelial cells Free Radic Biol Med 40 2006 1034 1044 (Pubitemid 43376013)
21. R. Layfield, and R.J. Mayer The ubiquitin proteasome system in human disease Biochim Biophys Acta 1782 2008 681 682
22. E.A. Lee, J.Y. Seo, Z. Jiang, M.R. Yu, M.K. Kwon, and H. Ha Reactive oxygen species mediate high glucose-induced plasminogen activator inhibitor-1 up-regulation in mesangial cells and in diabetic kidney Kidney Int 67 2005 1762 1771 (Pubitemid 40577711)
23. E.A. Lee, J.Y. Seo, Z. Jiang, M.R. Yu, M.K. Kwon, and H. Ha Reactive oxygen species mediate high glucose-induced plasminogen activator inhibitor-1 up-regulation in mesangial cells and in diabetic kidney Kidney Int 67 2005 1762 1771 (Pubitemid 40577711)
24. J.M. Li, and A.M. Shah ROS generation by nonphagocytic NADPH oxidase: potential relevance in diabetic nephropathy J Am Soc Nephrol 14 2003 S221 S226
25. C.S. Lim, and N.D. Vaziri The effects of iron dextran on the oxidative stress in cardiovascular tissues of rats with chronic renal failure Kidney Int 65 2004 1802 1809 (Pubitemid 38591029)
26. M. Lorenz, N. Wilck, S. Meiners, A. Ludwig, G. Baumann, and K. Stangl Proteasome inhibition prevents experimentally-induced endothelial dysfunction Life Sci 84 2009 929 934
27. J. Lundgren, P. Masson, Z. Mirzaei, and P. Young Identification and characterization of a Drosophila proteasome regulatory network Mol Cell Biol 25 2005 4662 4675 (Pubitemid 40705769)
28. M. Majetschak, M.B. Patel, L.T. Sorell, C. Liotta, S. Li, and S.M. Pham Cardiac proteasome dysfunction during cold ischemic storage and reperfusion in a murine heart transplantation model Biochem Biophys Res Commun 365 2008 882 888 (Pubitemid 350234876)
29. R. Marfella, C. Di Filippo, M. Portoghese, M. Siniscalchi, S. Martis, and F. Ferraraccio The ubiquitin-proteasome system contributes to the inflammatory injury in ischemic diabetic myocardium: the role of glycemic control Cardiovasc Pathol 18 2009 332 345
30. M. McMahon, K. Itoh, M. Yamamoto, and J.D. Hayes Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression J Biol Chem 278 2003 21592 21600 (Pubitemid 36792558)
31. S. Meiners, D. Heyken, A. Weller, A. Ludwig, K. Stangl, and P.M. Kloetzel Inhibition of proteasome activity induces concerted expression of proteasome genes and de novo formation of Mammalian proteasomes J Biol Chem 278 2003 21517 21525 (Pubitemid 36792549)
32. S. Meiners, A. Ludwig, M. Lorenz, H. Dreger, G. Baumann, and V. Stangl Nontoxic proteasome inhibition activates a protective antioxidant defense response in endothelial cells Free Radic Biol Med 40 2006 2232 2241 (Pubitemid 43922398)
33. V. Menendez-Benito, L.G. Verhoef, M.G. Masucci, and N.P. Dantuma Endoplasmic reticulum stress compromises the ubiquitin-proteasome system Hum Mol Genet 14 2005 2787 2799 (Pubitemid 41418785)
34. E.P. Mensah-Brown, E.N. Obineche, S. Galadari, E. Chandranath, A. Shahin, and I. Ahmed Streptozotocin-induced diabetic nephropathy in rats: the role of inflammatory cytokines Cytokine 31 2005 180 190 (Pubitemid 40967901)
35. S. Mezzano, C. Aros, A. Droguett, M.E. Burgos, L. Ardiles, and C. Flores NF-kappaB activation and overexpression of regulated genes in human diabetic nephropathy Nephrol Dial Transplant 19 2004 2505 2512 (Pubitemid 39360096)
36. J.F. Navarro, F.J. Milena, C. Mora, C. Leon, and J. Garcia Renal pro-inflammatory cytokine gene expression in diabetic nephropathy: effect of angiotensin-converting enzyme inhibition and pentoxifylline administration Am J Nephrol 26 2006 562 570 (Pubitemid 46143878)
37. J.F. Navarro, and C. Mora Role of inflammation in diabetic complications Nephrol Dial Transplant 20 2005 2601 2604 (Pubitemid 41672253)
38. J.F. Navarro, and C. Mora The role of inflammatory cytokines in diabetic nephropathy J Am Soc Nephrol 19 2008 433 442
39. E.D. Owuor, and A.N. Kong Antioxidants and oxidants regulated signal transduction pathways Biochem Pharmacol 64 2002 765 770 (Pubitemid 35238028)
40. D. Paglia, and W. Valentine Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase J Lab Clin Med 70 1967 158 169
41. T.H. Pohlman, and J.M. Harlan Adaptive responses of the endothelium to stress J Surg Res 89 2000 85 119 (Pubitemid 30127447)
42. S.K. Sahni, E. Rydkina, and A. Sahni The proteasome inhibitor MG132 induces nuclear translocation of erythroid transcription factor Nrf2 and cyclooxygenase-2 expression in human vascular endothelial cells Thromb Res 122 2008 820 825
43. B. Skaug, X. Jiang, and Z.J. Chen The role of ubiquitin in NF-kappaB regulatory pathways Annu Rev Biochem 78 2009 706 769
44. P.C. Stafylas, P.A. Sarafidis, A.N. Lasaridis, E. Tsakni, D.A. Niakas, and N.V. Dombros Cost-effectiveness of losartan in diabetic nephropathy: a Greek perspective J Nephrol 20 2007 703 715 (Pubitemid 351266124)
45. K. Stangl, and V. Stangl The ubiquitin-proteasome pathway and endothelial (dys) function Cardiovasc Res 85 2010 281 290
46. V. Thallas-Bonke, S.R. Thorpe, M.T. Coughlan, K. Fukami, F.Y. Yap, and K.C. Sourris Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway Diabetes 57 2008 460 469
47. T. Tomohiro, T. Kumai, T. Sato, Y. Takeba, S. Kobayashi, and K. Kimura Hypertension aggravates glomerular dysfunction with oxidative stress in a rat model of diabetic nephropathy Life Sci 80 2007 1364 1372 (Pubitemid 46367061)
48. K.R. Tuttle Linking metabolism and immunology: diabetic nephropathy is an inflammatory disease J Am Soc Nephrol 16 2005 1537 1538 (Pubitemid 41716459)
49. J. Wang, and M.A. Maldonado The ubiquitin-proteasome system and its role in inflammatory and autoimmune diseases Cell Mol Immunol 3 2006 255 261